[HTML][HTML] Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational …
Background Non-small cell lung cancer (NSCLC) patients harboring epidermal growth factor
receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine …
receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine …
Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study
YH Chen, YF Chen, CY Chen, JY Shih… - BMC …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Non-small cell lung cancer (NSCLC) patients harboring epidermal growth factor
receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine …
receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine …
Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study.
YH Chen, YF Chen, CY Chen, JY Shih, CJ Yu - BMC Cancer, 2019 - europepmc.org
BACKGROUND: Non-small cell lung cancer (NSCLC) patients harboring epidermal growth
factor receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR …
factor receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR …
[HTML][HTML] Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational …
YH Chen, YF Chen, CY Chen, JY Shih… - BMC …, 2019 - bmccancer.biomedcentral.com
Non-small cell lung cancer (NSCLC) patients harboring epidermal growth factor receptor
(EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine kinase …
(EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine kinase …
[HTML][HTML] Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational …
YH Chen, YF Chen, CY Chen, JY Shih, CJ Yu - BMC Cancer, 2019 - ncbi.nlm.nih.gov
Background Non-small cell lung cancer (NSCLC) patients harboring epidermal growth factor
receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine …
receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine …
Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study
YH Chen, YF Chen, CY Chen, JY Shih, CJ Yu - BMC Cancer, 2019 - infona.pl
Background Non-small cell lung cancer (NSCLC) patients harboring epidermal growth factor
receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine …
receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine …
Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study.
YH Chen, YF Chen, CY Chen, JY Shih, CJ Yu - BMC Cancer, 2019 - go.gale.com
Background Non-small cell lung cancer (NSCLC) patients harboring epidermal growth factor
receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine …
receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine …
Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study.
YH Chen, YF Chen, CY Chen, JY Shih, CJ Yu - BMC Cancer, 2019 - europepmc.org
BACKGROUND: Non-small cell lung cancer (NSCLC) patients harboring epidermal growth
factor receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR …
factor receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR …
[PDF][PDF] Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational …
YH Chen, YF Chen, CY Chen, JY Shih, CJ Yu - 2019 - bmccancer.biomedcentral.com
Background: Non-small cell lung cancer (NSCLC) patients harboring epidermal growth
factor receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR …
factor receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR …